Clinical Trials Browser

OTHER × Fibroma × Imatinib Mesylate × Clear all

NCT02495519 2020-01-14

A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)

Phase 2 Completed

Fibroma